Andrew C. von Eschenbach
   HOME

TheInfoList



OR:

Andrew C. von Eschenbach (born October 30, 1941) was the Commissioner of the
United States The United States of America (U.S.A. or USA), commonly known as the United States (U.S. or US) or America, is a country primarily located in North America. It consists of 50 states, a federal district, five major unincorporated territori ...
Food and Drug Administration The United States Food and Drug Administration (FDA or US FDA) is a List of United States federal agencies, federal agency of the United States Department of Health and Human Services, Department of Health and Human Services. The FDA is respon ...
from 2006 to 2009. He became acting Commissioner on September 26, 2005, after the resignation of his predecessor Lester Crawford, and was confirmed as Commissioner by the Senate on December 7, 2006.Senate Vote No. 274
/ref> He was previously the 12th director of the
National Cancer Institute The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. ...
. Von Eschenbach currently serves on the board of directors of
BioTime Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house devel ...
, a
biotechnology Biotechnology is the integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services. The term ''biotechnology'' was first used ...
company helmed by CEO Michael D. West. He also serves as a director of Viamet Pharmaceuticals.


Biography

After graduating from St. Joseph's Preparatory School, von Eschenbach received his bachelor of science in biology from
St. Joseph's University Saint Joseph's University (SJU or St. Joe's) is a private Jesuit university in Philadelphia and Lower Merion, Pennsylvania. The university was founded by the Society of Jesus in 1851 as Saint Joseph's College. Saint Joseph's is the seventh olde ...
in 1963 and his MD from
Georgetown University School of Medicine Georgetown University School of Medicine, a medical school opened in 1851, is one of Georgetown University's five graduate schools. It is located on Reservoir Road in the Georgetown neighborhood of Washington, DC, adjacent to the University's ...
in 1967. He did residencies at
Pennsylvania Hospital Pennsylvania Hospital is a private, non-profit, 515-bed teaching hospital located in Center City Philadelphia and is part of the University of Pennsylvania Health System. Founded on May 11, 1751, by Benjamin Franklin and Dr. Thomas Bond, Pennsyl ...
in general surgery and
urology Urology (from Greek οὖρον ''ouron'' "urine" and '' -logia'' "study of"), also known as genitourinary surgery, is the branch of medicine that focuses on surgical and medical diseases of the urinary-tract system and the reproductive org ...
and taught urology at the
University of Pennsylvania School of Medicine The Perelman School of Medicine, commonly known as Penn Med, is the medical school of the University of Pennsylvania, a private research university in Philadelphia, Pennsylvania. Founded in 1765, the Perelman School of Medicine is the oldest medi ...
. He served in the US Navy Medical Corps with the rank of
lieutenant commander Lieutenant commander (also hyphenated lieutenant-commander and abbreviated Lt Cdr, LtCdr. or LCDR) is a commissioned officer rank in many navies. The rank is superior to a lieutenant and subordinate to a commander. The corresponding ran ...
from 1968 to 1971. In 1976, von Eschenbach began his long association with The University of Texas M. D. Anderson Cancer Center, beginning as a urologic oncology fellow, and becoming chair of the department of urology in 1983. He was founding director of the Prostate Cancer Research Program in 1996, director of the
Genitourinary The genitourinary system, or urogenital system, are the organs of the reproductive system and the urinary system. These are grouped together because of their proximity to each other, their common embryological origin and the use of common pathw ...
Cancer Center, and held the Roy M. and Phyllis Gough Huffington Clinical Research Distinguished Chair in Urologic Oncology. Driven by his father's prostate cancer, he specialized in the disease. Von Eschenbach was president-elect of the American Cancer Society when he was selected by President
George W. Bush George Walker Bush (born July 6, 1946) is an American politician who served as the 43rd president of the United States from 2001 to 2009. A member of the Republican Party, Bush family, and son of the 41st president George H. W. Bush, he ...
to head the NCI in December 2001. As director of the NCI he announced in 2003 that his organization's goal was to "eliminate suffering and death" caused by cancer by the year 2015. However, under von Eschenbach's leadership the FDA has been criticized for being too risk averse when considering life saving treatments for desperate, dying patients. For example, in 2007 the FDA failed to approve
Provenge Sipuleucel-T, sold under the brand name Provenge, developed by Dendreon Pharmaceuticals, LLC, is a cell-based cancer immunotherapy for prostate cancer (CaP). It is an autologous cellular immunotherapy. Medical uses Sipuleucel-T is indicated ...
for the treatment of late stage prostate cancer against the recommendation of an independent advisory committee. Von Eschenbach was criticized for overruling his staff recommendations, and approving the Menaflex knee implant, made by ReGen Biologics Inc., New Jersey, on a fast-track basis, after four New Jersey congressmen lobbied on ReGen's behalf. Von Eschenbach said, "We fumbled that process." In 2006, ''
Time Time is the continued sequence of existence and events that occurs in an apparently irreversible succession from the past, through the present, into the future. It is a component quantity of various measurements used to sequence events, ...
'' named him as one of the Time 100 "People Who Shape Our World", writing that as head of the FDA, which "wields enormous influence on American lives", von Eschenbach "could make a signal contribution to the public's health" by focusing on issues of diet and obesity in addition to drugs and disease. On August 1, 2006, Senators Clinton and Cantwell announced they would block his nomination to be the permanent FDA commissioner because of his department's failure to act on the application by Barr Pharmaceuticals to sell Plan B
over-the-counter Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescr ...
. They ultimately voted for his nomination. Eschenbach left the FDA in 2009 to join Greenleaf Health, which counsels pharmaceutical clients, before starting his own consulting company, Samaritan Health Initiatives.Nonprofit Working To Block Drug Imports Has Ties To Pharma Lobby
by Emily Kopp & Rachel Bluth for NPR and Kaiser Health News, April 18, 2017
Andrew von Eschenbach was instrumental in the development and growth of the Prostate Cancer Foundation (founded by
Michael Milken Michael Robert Milken (born July 4, 1946) is an American financier. He is known for his role in the development of the market for high-yield bonds ("junk bonds"), and his conviction and sentence following a guilty plea on felony charges for vio ...
) since its inception in 1993 and held a board membership position and scientific advisor role at the foundation. C-Change, a forum that brings together the principal leaders of key national cancer organizations, and founded by Andrew von Eschenbach, is in partnership with the Prostate Cancer Foundation.


References

* "Andrew von Eschenbach." Biography Resource Center Online. Gale, 2006.


External links

* {{DEFAULTSORT:Eschenbach, Andrew Von 1941 births Living people St. Joseph's Preparatory School alumni Saint Joseph's University alumni Commissioners of the Food and Drug Administration Georgetown University School of Medicine alumni Physicians from Philadelphia United States Navy Medical Corps officers George W. Bush administration personnel